Overview

Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer

Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety and efficacy of Apatinib plus S-1 as the Therapy of Advanced Colorectal Cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Henan Cancer Hospital
Collaborator:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Apatinib